Inflammatory Bowel Diseases (IBD), including Crohn’s Disease and Ulcerative Colitis, require long-term clinical monitoring. Disease exacerbations (flares) are often unexpected and associated with acute abdominal pain, diarrhea, and frequent hospitalization. However, regular outpatient consultations only provide episodic data reflecting a specific moment in time and fail to capture the dynamics of disease symptoms over an extended period.
New research reviews leading U.S. mobile applications and specifically examines WITH-Jang, a Korean platform created through the collaboration of patients and clinicians. The application monitors symptoms using the Mayo index and CDAI score, and also records medications and dietary data. The application uses Patient-Reported Outcomes (PROs) to create structured clinical reports for clinicians.
This technological innovation is vitally important because IBD affects 4.9 million people globally, accompanied by a sharp decline in quality of life caused by chronic stress, social isolation, and financial burden. These digital platforms ensure continuous remote monitoring, sharply reduce the need for hospitalization, promote personalized treatment, enable the proactive prediction of flares, and strengthen the patient’s role in managing their own disease.
Six Leading, Validated U.S. IBD Applications:
Expert Assessments
Adam Barton, MD (Brown University): Oshi combines multidisciplinary approaches—psychological support is crucial for overcoming anxiety, which often exacerbates gastrointestinal (GI) symptoms. Trellus, however, needs large-scale research to prove the potential of holistic IBD management.
Joseph Sleimany, MD (Cleveland Clinic): Ayble is popular among young patients; dietitians ensure the integration of data flow into Electronic Health Records (EHR).
Additional Digital Platforms:
My IBD Care (focused on well-being, sleep, and stress management).
MyGut (a platform for documenting symptoms and discussion with a doctor).
We Can’t Wait (an application for finding public restrooms).
mySymptoms (an application for identifying food triggers).
Wearable Devices:
Applications require active data entry; wearable devices, however, passively collect information. Dr. Robert Herten(Mount Sinai) notes:
A 6-month study of smart devices (Apple/Fitbit/Oura) on 309 patients determined that changes in parameters like Heart Rate Variability (HRV), physical activity (steps), and blood oxygen saturation were recorded 7 weeks before the clinical manifestation of a flare. A reduction in the number of steps indicates a systemic inflammatory process. Furthermore, a sleep study (101 patients) revealed: the disorganization of sleep “structure” directly correlates with disease activity and is not just an accompanying symptom.
The use of the IBD AWARE transdermal sensor achieved the detection of the inflammatory marker TNF-alpha: the recorded level was , while in healthy individuals, this indicator was (). This technology made it possible to obtain quantitative data equivalent to a blood test non-invasively (without blood).
The Emerald home sensor: This system monitors sleep phases, breathing rate, and walking manner by detecting Wi-Fi waves. It can predict a disease flare up to 25 days in advance.
As Dr. Herten notes: “Passive monitoring and clinical prediction of IBD are fully achievable.”
WITH-Jang: A Patient-Oriented Digital Tool
The application WITH-Jang was created in South Korea in response to the growing statistics of IBD (high incidence: Crohn’s ; Ulcerative Colitis ). Its uniqueness lies in the design created through the joint work of patients and clinicians. The application is based on six core needs, including: personalized symptom control (Mayo/CDAI standards), reliable medical information, and data utilization.
Design and Clinical Evaluation: After evaluating the prototypes, which showed high scores (e.g., reminders ), testing began. A 4-week test involving 20 patients confirmed the efficacy of WITH-Jang (), which exceeds the results of other similar applications. Users were mainly satisfied with the function of identifying food triggers and the effectiveness of timely reminders.
Final Update: The main innovations of the V1.0 update are the automatic recording of a patient’s adherence to medication prescriptions and the generation of a “My WITH-Jang Report” in PDF format for clinicians. These structured reports combine symptomatic trends and dietary data, thereby ensuring full compliance between the patient’s subjective needs and objective clinical requirements.
Dr. Sleiman’s Guide for Clinicians:
HIPAA Standards/Consent: Requires full vetting of the application provider and patient consent for the use of records.
Alert Management: It is essential to precisely define the responsible party (who manages the alerts?) within the 24/7 monitoring framework.
Clinical Workflow: Digital platforms must save the doctor’s time and not overburden them.
Global Perspective:
The growth of the mHealth sector is expected to reach billion by 2030 (with a 40% Compound Annual Growth Rate – CAGR). Applications and wearable technologies reduce clinical visits and increase patients’ quality of life. WITH-Jang confirms that patient-oriented design yields effective results. The paradigm of medicine is transforming: from episodic symptom data to continuous “narratives,” and from reactive action to proactive prediction.
Source: BMC Health Services Research; Medscape
